Autologous human dermal fibroblasts cells therapy (Tego Science)

N/A

Report date: 2024/03/12 17:53:29

Base Information

Drug NameAutologous human dermal fibroblasts cells therapy (Tego Science)
Drug Alias NameRosmirTPX-105
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Somatic cell > Dermal fibroblasts therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsNasolabial fold wrinklesEyelid Diseases
Global Approved IndicationsNasolabial fold wrinkles
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2017/01/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTego Science Inc
China Registration ClassN/A

Develop Information

Active CompaniesTego Science IncTego Sciences
Inactive CompaniesN/A
Active IndicationsNasolabial fold wrinklesEyelid Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A